We performed, for possible therapeutic application, low density lipoprotein apheresis (LDL-A) in conjunction with double filtration plasmapheresis (DEPP) in 5 patients with drug-resistant nephrotic syndrome due to focal glomerular sclerosis (FGS). The possible relationship between changes of renal function and correction of lipid abnormalities was investigated. The creatinine clearance (Ccr) and renal blood flow (RBF) were increased by LDL-A and DFPP in all patients, and the remission of renal function and proteinuria followed a reduction in serum lipid levels. We next followed the changes in putative non-immune parameters of glomerular disease, such as flbrinopeptide A (FPA), fibrinopeptide Bβ15-42 (FPBβ15-42), thromboxane B
2 (TxB
2) and 6-keto-prostaglandin F
1α (6-Keto-PG F
1α). The plasma FPA and FPBIβ15-42 levels, and the TxB
2/6-Keto-PGF
1α ratio were found to decrease followintg plasmapheresis. These results may provide some indication of the beneficial effects of LDL-A and DEPP on glomerular disease. In this report, we present a new approach for the treatment of drug-resistant nephrotic syndrome due to FGS. The data suggest that lipid abnormalities may, at least in part, play a pathogenetic role in progressive renal disease.
抄録全体を表示